Delivery Order SPE2DB22D7065-SPE2DB25FH3NB
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 31, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injectors. The contract, valued at $9,009, represents a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and was awarded through open competition with no set-aside designation. The product will be delivered to the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injections. The contract, valued at $4,379.01, represents a firm fixed price delivery order with an ultimate completion date of November 3, 2025. The place of performance is identified as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This award was competitively awarded without set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 5, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $4,088.04. The award is structured as a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 ml pen auto-injectors valued at $1,338.84. The order was competitively awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, under a firm fixed-price delivery order contract with no set-aside designation. The place of performance is AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,878.61 by the Defense Logistics Agency (DLA) on September 18, 2025, with a completion date of September 19, 2025. The contract covers the supply of Trulicity 1.5 mg/0.5 mL pen injectable medication, a diabetes treatment. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. The contract, valued at $3,488.88, carries a firm fixed-price structure with an ultimate completion date of December 5, 2025. This delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,922.70 by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract utilized firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed at the vendor's Conshohocken facility, with an ultimate completion date of November 26, 2025....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,453.70. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 26, 2025, and will be performed at the awardee's facility in Conshohocken, PA. The award represents a child order under...
- SPE2DB22D7065Indefinite Delivery Contract
- SPE2DB22D7065-SPE2DB25FH3NBDelivery Order
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor based in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 ml pen injectables with a ceiling value of $4,397.99. This contract, awarded on September 5, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 8, 2025. The award is not designated as a set-aside contract and was competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications across multiple therapeutic domains. The current award for Trulicity, a diabetes treatment medication, reflects the company's ongoing role as a key vendor for federal medical procurement needs serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/5/25 |